secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2022-09-13T23:59:59+00:00
Accession:  0001021771-22-000051
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 4.01, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative exchanges preferred shares with Auctus, replaces auditor after Friedman/Marcum merger
--------------------------------------------------------------------------------

- Issued 1,543,158 Series B preferred shares to Auctus Fund in exchange for same number of Series A shares on Sept 8, 2022.
- Series B preferred stock raises beneficial ownership limitation to 9.99% of common stock (up from 4.99% for Series A).
- Audit Committee dismissed Friedman LLP and engaged Marcum LLP as independent auditor on Sept 13, 2022, following Friedman's combination with Marcum.
- Friedman's reports for FY2020 and FY2021 were unqualified with no disagreements or reportable events.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000102177122000051/0001021771-22-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000102177122000051/form8kdtd090822.htm
  HTML page:      https://secwatch.observer/filing/0001021771-22-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer